Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

​ To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Read More

​ To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Chamber names 2025 Small Business of the Year Award recipients – Wausau Pilot & Review
I’ve Seen 25 Years of Change in My Career — These 3 Lessons Every Business Owner Should Know
Harvard’s bold stand against Trump’s bullying
Trump administration demands foreign funding records from Harvard